Assessment of the Efficacy of Certolizumab Pegol in the Maintenance of Response for the Treatment of Crohn's Disease

被引：0
|
作者：
Lee, Scott D.
Ko, Cynthia W.
Wahbeh, Ghassan
Cullinan, Cory
Etter, Scott
Sinanan, Mika N.
Wheat, Chelle
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S282 / S282
页数：1
相关论文
共 50 条
  • [21] Certolizumab pegol in Crohn's disease - A viewpoint
    Abreu, Maria T.
    BIODRUGS, 2007, 21 (03) : 202 - 203
  • [22] Certolizumab Pegol for Active Crohn's Disease
    Blackmore, Laura J.
    Harris, Adam W.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (03) : 327 - 327
  • [23] Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease
    Vande Casteele, N.
    Feagan, B. G.
    Vermeire, S.
    Yassine, M.
    Coarse, J.
    Kosutic, G.
    Sandborn, W. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (02) : 229 - 237
  • [24] Certolizumab pegol as treatment for Crohn's disease in a community IBD practice
    Shafran, Ira
    Burgunder, Patricia
    Fakih, Faisal
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S27 - S27
  • [25] Certolizumab pegol (CDP870) for treatment of Crohn's disease
    Sisson, G
    Harris, A
    GASTROENTEROLOGY, 2006, 130 (01) : 285 - 286
  • [26] Assessment of the Safety of Certolizumab Pegol for the Treatment of Crohn's Disease at a Single North American Center
    Lee, Scott
    Ko, Cynthia
    Wheat, Chelle
    Harper, Jason
    Cullinan, Cory
    Etter, Scott
    Pulling, Michele
    Sinanan, Mika
    Wahbeh, Ghassan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S471 - S472
  • [27] Risk-benefit Assessment of Adalimumab and Certolizumab Pegol as Induction Treatment for Crohn's Disease
    Colombel, Jean-Frederic
    Panaccione, R.
    Robinson, Anne
    Thakkar, Roopal
    Huang, Bidan
    Pollack, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S466 - S466
  • [28] Meta-analysis: the efficacy and safety of certolizumab pegol in Crohn's disease
    Shao, L. -M.
    Chen, M. -Y.
    Chen, Q. -Y.
    Cai, J. -T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (06) : 605 - 614
  • [29] Evaluation of pharmacokinetics and pharmacodynamics and clinical efficacy of certolizumab pegol for Crohn's disease
    Tun, Gloria S. Z.
    Lobo, Alan J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (02) : 317 - 327
  • [30] Certolizumab Pegol for the Management of Crohn's Disease in Adults
    Rivkin, Anastasia
    CLINICAL THERAPEUTICS, 2009, 31 (06) : 1158 - 1176
12345